Cardiac sympathetic denervation modulates the sympathoexcitatory response to acute myocardial ischemia

Shuji Joho1, Hidetsugu Asanoi, Junya Takagawa

  • 1Second Department of Internal Medicine, Toyama Medical and Pharmaceutical University, Toyama, Japan.

Insights

Cardiac sympathetic denervation may prevent ischemia-induced sympathoexcitation in patients with mild myocardial ischemia. This study investigated the impact of denervation on the sympathoexcitatory response during balloon coronary occlusion (BCO).

Area of Science:

  • Cardiology
  • Autonomic Nervous System
  • Myocardial Ischemia Research

Background:

  • Cardiac sympathetic nerve function alterations can influence sympathetic reflexes from ischemic regions.
  • Understanding these modulations is crucial for managing cardiac events.

Purpose of the Study:

  • To determine how cardiac sympathetic denervation affects the sympathoexcitatory response to acute myocardial ischemia.
  • Investigate the role of denervation during balloon coronary occlusion (BCO) in human subjects.

Main Methods:

  • Assessed cardiac sympathetic denervation using iodine-123 metaiodobenzylguanidine ((123)I-MIBG) in 23 angina patients.
  • Analyzed transient sympathetic activity changes during BCO via wavelet analysis of RR interval variability.

Main Results:

  • Patients without denervation showed a greater increase in low-frequency (LF) components of RR interval variability during BCO (273%) compared to those with denervation (34%).
  • This difference was significant, particularly in cases of mild ischemia, where denervated patients had a blunted response (84% vs. 344%).
  • Severe ischemia induced a significant sympathoexcitatory response regardless of denervation status.

Conclusions:

  • Cardiac sympathetic denervation appears to mitigate ischemia-induced sympathoexcitation, especially when the myocardial ischemia is not severe.
  • Findings suggest a potential therapeutic role for denervation in specific ischemic scenarios.
Abstract

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Sympathetic Activation01:16

Sympathetic Activation

The sympathetic division can influence tissues and organs by releasing norepinephrine at peripheral synapses and distributing epinephrine and norepinephrine through the bloodstream. In times of crisis or stress, sympathetic activation occurs, which is regulated by sympathetic centers in the hypothalamus. As a result, sympathetic activation prepares the body for physical exertion, rapid ATP production, and heightened alertness, allowing individuals to respond effectively to challenging or...
Regulation of Heart Rates01:31

Regulation of Heart Rates

The regulation of heart rate is a complex process controlled by the autonomic nervous system (ANS), hormonal influences, and intrinsic cardiac mechanisms. The ANS has two main components: the sympathetic nervous system (SNS) and the parasympathetic nervous system (PNS).
The SNS increases heart rate through the release of norepinephrine and epinephrine, which act on beta-1 adrenergic receptors in the heart. This action increases the rate of depolarization in the sinoatrial (SA) node, the heart's...
Sympathetic Signaling01:31

Sympathetic Signaling

Sympathetic signaling, a vital part of the autonomic nervous system, plays a crucial role in mobilizing the body's resources in response to stress or emergencies. It involves the transmission of nerve impulses from sympathetic preganglionic fibers to postganglionic fibers. This results in the release of specific neurotransmitters and activation of adrenergic receptors.
Sympathetic preganglionic fibers release the neurotransmitter acetylcholine (ACh) onto the ganglionic neurons in the...
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...